Aura Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Aura Biosciences, Inc. (AURA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents31.6941.06121.58149.0617.39
Short-Term Investments119.40185.0967.230.000.00
Cash & Short-Term Investments151.09226.15188.81149.0617.39
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets9.531.822.170.070.05
Total Current Assets160.62231.79196.70153.7018.46
Non-Current Assets
Property, Plant & Equipment (Net)20.5922.0026.046.203.57
Other Non-Current Assets1.291.281.190.130.08
Total Non-Current Assets21.8823.2827.236.330.00
Total Assets182.50255.08223.94160.0322.10
Current Liabilities
Accounts Payable2.301.792.922.400.61
Short-Term Debt3.150.000.000.000.00
Accrued Liabilities3.396.954.251.691.77
Other Current Liabilities9.460.940.330.510.28
Total Current Liabilities14.9112.3610.467.362.66
Non-Current Liabilities
Long-Term Debt15.6216.8717.900.360.00
Other Non-Current Liabilities0.000.000.000.000.08
Total Non-Current Liabilities15.6216.8717.900.360.00
Total Liabilities30.5329.2328.357.722.74
Stockholders' Equity
Retained Earnings-374.23-287.31-210.90-152.14-116.89
Accumulated Other Comprehensive Income0.260.54-0.070.000.00
Additional Paid-in Capital525.93512.62406.56304.450.00
Shares Outstanding50.0049.3537.7729.210.00
Total Stockholders' Equity151.97225.85195.58152.3219.36
Total Liabilities & Equity182.50255.08223.94160.030.00